335 related articles for article (PubMed ID: 18023707)
1. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.
Hobbs JE; Zakarija A; Cundiff DL; Doll JA; Hymen E; Cornwell M; Crawford SE; Liu N; Signaevsky M; Soff GA
Thromb Res; 2007; 120 Suppl 2():S13-21. PubMed ID: 18023707
[TBL] [Abstract][Full Text] [Related]
2. Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.
Signaevsky M; Hobbs J; Doll J; Liu N; Soff GA
Semin Thromb Hemost; 2008 Mar; 34(2):161-9. PubMed ID: 18645921
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis.
Goldin-Lang P; Tran QV; Fichtner I; Eisenreich A; Antoniak S; Schulze K; Coupland SE; Poller W; Schultheiss HP; Rauch U
Oncol Rep; 2008 Jul; 20(1):123-8. PubMed ID: 18575726
[TBL] [Abstract][Full Text] [Related]
4. Alternatively spliced human tissue factor (asHTF) is not pro-coagulant.
Censarek P; Bobbe A; Grandoch M; Schrör K; Weber AA
Thromb Haemost; 2007 Jan; 97(1):11-4. PubMed ID: 17200764
[TBL] [Abstract][Full Text] [Related]
5. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
Lai RX; Zhang SN; Nakamura T; Yuan SZ
Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
[TBL] [Abstract][Full Text] [Related]
6. Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma.
Kakkar AK; Chinswangwatanakul V; Lemoine NR; Tebbutt S; Williamson RC
Br J Surg; 1999 Jul; 86(7):890-4. PubMed ID: 10417560
[TBL] [Abstract][Full Text] [Related]
7. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines.
Szotowski B; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2005 Jun; 96(12):1233-9. PubMed ID: 15920023
[TBL] [Abstract][Full Text] [Related]
8. [In vivo effect of annexin I down-regulation on the growth of human pancreatic cancer in nude mice].
Liu Q; Hu H; Ran YL; Wang CF; Zhao DB; Tian YT; Sun LX; Xie YB; Yang ZH; Zhao P
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):897-900. PubMed ID: 19173988
[TBL] [Abstract][Full Text] [Related]
9. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.
Shi Q; Abbruzzese JL; Huang S; Fidler IJ; Xiong Q; Xie K
Clin Cancer Res; 1999 Nov; 5(11):3711-21. PubMed ID: 10589791
[TBL] [Abstract][Full Text] [Related]
10. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J
Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.
Rak J; Milsom C; May L; Klement P; Yu J
Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463
[TBL] [Abstract][Full Text] [Related]
12. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
13. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.
Bogdanov VY; Balasubramanian V; Hathcock J; Vele O; Lieb M; Nemerson Y
Nat Med; 2003 Apr; 9(4):458-62. PubMed ID: 12652293
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy.
Yu JL; May L; Klement P; Weitz JI; Rak J
Semin Thromb Hemost; 2004 Feb; 30(1):21-30. PubMed ID: 15034795
[TBL] [Abstract][Full Text] [Related]
16. [The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer].
Fang J; Wei WN; Xia LH; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):523-7. PubMed ID: 15569528
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
[TBL] [Abstract][Full Text] [Related]
19. HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.
Lokeshwar VB; Estrella V; Lopez L; Kramer M; Gomez P; Soloway MS; Lokeshwar BL
Cancer Res; 2006 Dec; 66(23):11219-27. PubMed ID: 17145867
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.
Khorana AA; Ahrendt SA; Ryan CK; Francis CW; Hruban RH; Hu YC; Hostetter G; Harvey J; Taubman MB
Clin Cancer Res; 2007 May; 13(10):2870-5. PubMed ID: 17504985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
